After over a decade of work, Breast Cancer Now-funded researchers have found a new potential treatment option for women living with BRCA mutated secondary breast cancer. New research has now revealed that a one year course of this treatment can help to reduce the risk of breast cancer recurrence, and progression to secondary breast cancer, in people with early breast cancer with a change in the BRCA gene.
New research has revealed that a one year course of a drug called a PARP inhibitor can help to reduce the risk of breast cancer recurrence, and progression to secondary breast cancer, in people with early breast cancer with a change in the BRCA gene.
This week, we're taking a quick peek into the research side of things with our Research Communications Officer, Edd.
His Royal Highness met with researchers, donors and supporters to hear about our achievements and how the COVID-19 pandemic has impacted our funded research.
In collaboration with others, Breast Cancer Now has supported research into helping women make sustainable lifestyle changes in order to reduce breast cancer risk.
Have you ever wondered how scientists discover new drugs? In this blog, we explore the journey research takes from the initial questions to new drugs.
New research reveals that hot flushes and night sweats experienced by women with breast cancer could be reduced through cognitive behavioural therapy (CBT) delivered by breast care nurses.
It's thanks to your support that our researchers can continue to find new ways to prevent breast cancer, save lives and make sure people live well with and beyond the disease.
Forty years ago, only one in two women would live five years or more after a breast cancer diagnosis. Thanks to progress in research and care, it’s now almost nine in 10.